HUITONGDA NET (09878) Implements Full Circulation of H Shares and Obtains Listing Approval from the Hong Kong Stock Exchange

20:02 22/01/2026

Huixunda Network (09878) announced that it plans to implement full circulation of H shares. The company has received approval from the Hong Kong Stock Exchange on January 21, 2026 for the listing of 349,749,813 H shares.

HUITONGDA NET (09878) announced that it plans to implement full circulation of H shares. The company has received approval from the Hong Kong Stock Exchange on January 21, 2026 for the listing of 349,749,813 H shares. The company will complete the relevant conversion and trading procedures for the H shares. This move will enhance the liquidity and market influence of H shares, and create positive conditions for future re-inclusion in the Hong Kong Stock Connect.

LINGBAO GOLD (03330): Huang Hui appointed as independent non-executive director.

LEADS BIOLABS-B(09887): Vitrakvi has been granted orphan drug designation (ODD) by the European Commission for the treatment of pulmonary neuroendocrine tumors.

MACAU LEGEND (01680) raised approximately HK$86.4 million from the issuance of new shares.

LINGBAO GOLD (03330): Huang Hui appointed as independent non-executive director.

LEADS BIOLABS-B(09887): Vitrakvi has been granted orphan drug designation (ODD) by the European Commission for the treatment of pulmonary neuroendocrine tumors.

MACAU LEGEND (01680) raised approximately HK$86.4 million from the issuance of new shares.